Ned Scheetz
Managing Partner at Aphelion Capital
Denver, Colorado
Overview
Work Experience
Founder & Managing Partner
2005 - Current
Aphelion Capital is a venture capital firm focused on the creation and growth of innovative medical technology and digital health companies
Member Board Of Directors
2015
Member Board Of Directors
2013
CyMedica Orthopedics develops and commercializes products that target joint injuries and the resulting muscle atrophy.
Raised $27,589,307.00 from Aphelion Capital, Research Corporation Technologies and California Technology Ventures.
Member Board Of Directors
2013
Mercator MedSystems develops site-specific delivery devices for the treatment of vascular, oncologic, and regenerative diseases.
Raised $23,333,502.00 from Shenzhen Salubris Pharmaceuticals.
Member Board Of Directors
2011
ClearFlow is a medical device company developing technologies to solve clinical problems associated with obstructed catheters.
Raised $39,699,452.00 from Research Corporation Technologies, Aphelion Capital and California Technology Ventures.
Member Board Of Directors
2009 - 2017
Catheter Connections develops vascular access products to protect patients from acquiring infections during intravenous infusion therapy.
Raised $7,661,722.00 from Sand Hill Angels, vSpring Capital and Kickstart.
Member Board Of Directors
2006 - 2016
SurgiQuest is a surgical device company in the field of minimally-invasive access technology.
Raised $65,333,092.00 from RC Capital, Aphelion Capital, Presidio Partners, California Technology Ventures and Fletcher Spaght, Inc..
Member Board Of Directors
2014 - 2015
Providence Medical Technology is a privately-held medical device company focused on innovative solutions for cervical spinal conditions.
Raised $101,300,000.00 from Armentum Partners and Bridge Bank.
Co-Founder & Member Board of Directors
2004 - 2012
Member Board Of Directors
2007 - 2011
OrthoScan, a medical device company, provides solutions for orthopedic imaging applications in the United States.
Raised $8,325,000.00 from California Technology Ventures, RC Capital and Aphelion Capital.